UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 68 filers reported holding UTAH MED PRODS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $999,344 | -5.5% | 11,581 | +2.4% | 0.20% | -4.7% |
Q2 2023 | $1,057,325 | -0.4% | 11,309 | +1.3% | 0.21% | -3.2% |
Q1 2023 | $1,061,473 | -5.2% | 11,166 | +0.3% | 0.22% | -7.6% |
Q4 2022 | $1,119,502 | +19.3% | 11,136 | +1.3% | 0.24% | +7.2% |
Q3 2022 | $938,000 | +1.1% | 10,997 | +1.8% | 0.22% | +4.7% |
Q2 2022 | $928,000 | -2.4% | 10,803 | +2.1% | 0.21% | +10.4% |
Q1 2022 | $951,000 | -5.8% | 10,584 | +4.8% | 0.19% | -4.0% |
Q4 2021 | $1,010,000 | +7.8% | 10,097 | +0.0% | 0.20% | -1.5% |
Q3 2021 | $937,000 | +9.8% | 10,093 | +0.7% | 0.20% | +12.8% |
Q2 2021 | $853,000 | -1.3% | 10,025 | +0.5% | 0.18% | -5.8% |
Q1 2021 | $864,000 | +4.5% | 9,978 | +1.7% | 0.19% | -2.6% |
Q4 2020 | $827,000 | +8.2% | 9,810 | +2.5% | 0.20% | -6.7% |
Q3 2020 | $764,000 | -6.9% | 9,571 | +3.2% | 0.21% | -11.0% |
Q2 2020 | $821,000 | -14.9% | 9,272 | -9.7% | 0.24% | -26.0% |
Q1 2020 | $965,000 | -7.7% | 10,270 | +5.9% | 0.32% | +17.3% |
Q4 2019 | $1,046,000 | +11.0% | 9,694 | -1.4% | 0.27% | +4.6% |
Q3 2019 | $942,000 | -0.8% | 9,829 | -1.0% | 0.26% | -3.7% |
Q2 2019 | $950,000 | +6.0% | 9,924 | -2.4% | 0.27% | +5.5% |
Q1 2019 | $896,000 | +7.4% | 10,163 | +1.2% | 0.26% | -6.9% |
Q4 2018 | $834,000 | -10.0% | 10,040 | +1.9% | 0.28% | +5.0% |
Q3 2018 | $927,000 | -14.4% | 9,848 | +0.1% | 0.26% | -20.1% |
Q2 2018 | $1,083,000 | +11.9% | 9,835 | +0.3% | 0.33% | +7.9% |
Q1 2018 | $968,000 | +20.1% | 9,802 | -1.0% | 0.30% | +24.6% |
Q4 2017 | $806,000 | +10.1% | 9,900 | -0.6% | 0.24% | +5.6% |
Q3 2017 | $732,000 | +10.1% | 9,962 | +8.5% | 0.23% | +5.0% |
Q2 2017 | $665,000 | +34.3% | 9,180 | +15.5% | 0.22% | +22.9% |
Q1 2017 | $495,000 | -13.3% | 7,945 | +1.3% | 0.18% | -17.5% |
Q4 2016 | $571,000 | +38.9% | 7,842 | +14.1% | 0.22% | +34.8% |
Q3 2016 | $411,000 | +3.3% | 6,870 | +8.8% | 0.16% | -0.6% |
Q2 2016 | $398,000 | +6.1% | 6,312 | +5.4% | 0.16% | +3.2% |
Q1 2016 | $375,000 | +15.0% | 5,989 | +7.6% | 0.16% | +7.5% |
Q4 2015 | $326,000 | +13.2% | 5,568 | +4.3% | 0.15% | +8.1% |
Q3 2015 | $288,000 | +4.0% | 5,337 | +14.9% | 0.14% | +11.6% |
Q2 2015 | $277,000 | +23.7% | 4,644 | +23.9% | 0.12% | +27.4% |
Q1 2015 | $224,000 | – | 3,748 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 42,000 | $3,899,000 | 5.84% |
Clean Yield Group | 16,590 | $1,540,000 | 0.50% |
RICE HALL JAMES & ASSOCIATES, LLC | 114,785 | $10,657,000 | 0.39% |
Ranger Investment Management | 68,719 | $6,380,000 | 0.34% |
ISTHMUS PARTNERS, LLC | 17,260 | $1,602,000 | 0.29% |
Cardinal Capital Management | 10,093 | $937,000 | 0.20% |
GLOBEFLEX CAPITAL L P | 6,336 | $588,000 | 0.13% |
Ancora Advisors LLC | 31,362 | $2,912,000 | 0.08% |
Penobscot Investment Management Company, Inc. | 4,000 | $371,000 | 0.06% |
SEIZERT CAPITAL PARTNERS, LLC | 10,430 | $968,000 | 0.04% |